[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …
Polypharmacy among COVID-19 patients: A systematic review
Background Polypharmacy, the concomitant use of 5 or more medications, is highly
prevalent among older adults and individuals with multimorbid conditions and has been …
prevalent among older adults and individuals with multimorbid conditions and has been …
Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus
The SARS-CoV-2 outbreak has posed a plethora of problems for the global healthcare
system and socioeconomic burden. Despite valiant efforts to contain the COVID-19 …
system and socioeconomic burden. Despite valiant efforts to contain the COVID-19 …
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
Since the outbreak emerged in November 2019, no effective drug has yet been found
against SARS-CoV-2. Repositioning studies of existing drug molecules or candidates are …
against SARS-CoV-2. Repositioning studies of existing drug molecules or candidates are …
Safety of short-term treatments with oral chloroquine and hydroxychloroquine in patients with and without COVID-19: a systematic review
S Marin, A Martin Val, M Bosch Peligero… - Pharmaceuticals, 2022 - mdpi.com
Chloroquine (CQ) and hydroxychloroquine (HCQ) have recently become the focus of global
attention as possible treatments for Coronavirus Disease 2019 (COVID-19). The current …
attention as possible treatments for Coronavirus Disease 2019 (COVID-19). The current …
COVID-19: fisiopatología y propuestas terapéuticas en investigación clínica
G Guzmán Valdivia Gómez, AD Domínguez González… - 2020 - repositorio.lasalle.mx
La pandemia por COVID-19 declarada por la Organización Mundial de la Salud el 11 de
marzo del 2020, ha ocasionado al momento 14,655,405 casos y 609,198 muertes en todo el …
marzo del 2020, ha ocasionado al momento 14,655,405 casos y 609,198 muertes en todo el …
Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta‐analysis
T Gupta, P Thakkar, B Kalra… - Reviews in medical …, 2022 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) caused by the novel severe acute
respiratory syndrome coronavirus 2 continues to grow and spread throughout the world …
respiratory syndrome coronavirus 2 continues to grow and spread throughout the world …
Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection
V Yathindranath, N Safa, MM Tomczyk… - International Journal …, 2024 - Taylor & Francis
Purpose The global pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and the lingering threat to public health has fueled the search for effective …
(SARS-CoV-2) and the lingering threat to public health has fueled the search for effective …
[HTML][HTML] A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition
R Dey-Rao, GR Smith, U Timilsina, Z Falls… - Antiviral research, 2021 - Elsevier
The likelihood of continued circulation of COVID-19 and its variants, and novel
coronaviruses due to future zoonotic transmissions, combined with the current paucity of …
coronaviruses due to future zoonotic transmissions, combined with the current paucity of …
[HTML][HTML] Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway epithelia
D Bovard, M van der Toorn, WK Schlage… - … and Biophysics Reports, 2022 - Elsevier
Iota-carrageenan (IC) nasal spray, a medical device approved for treating respiratory viral
infections, has previously been shown to inhibit the ability of a variety of respiratory viruses …
infections, has previously been shown to inhibit the ability of a variety of respiratory viruses …